Send the following on WhatsApp
Continue to ChatLow disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study - https://avesis.gazi.edu.tr/yayin/0713e219-863d-4f60-af64-409fd6713c87/low-disease-activityirrespective-of-serologic-status-at-baselineassociated-with-reduction-of-corticosteroid-dose-and-number-of-flares-in-patients-with-systemic-lupus-erythematosus-treated-with-belimumab-a-real-life-observational-study